K Number
K180983
Device Name
Maxcon Two Gallon Chemotherapy Container
Date Cleared
2019-01-03

(265 days)

Product Code
Regulation Number
880.5570
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
Maxcon Two Gallon Chemotherapy Container (Model, MC1321) is intended for safe collection and containment of trace chemotherapy waste including needles, syringes, and empty vials. The container is non-sterile, to be single-used in areas with controlled access, such as nurse's stations, pharmacies and chemo treatment rooms, and the target population is for trained health-care professionals.
Device Description
Maxcon Two Gallon Chemotherapy Container (Model: MC1321) is of 2 gallon capability, weight about 470gram, size of 275.6mm (length) ×181.5mm (width)× 275mm (height), and the maximum allowable gross mass of the container defined by the company is 2 Kg.There is no feature to bend, break, or shear needle (includes blunting and melting of needle)in the containers. The container is made of base+gasketed cap+screw-on cap. The plastic components are made of injection-moulded of Poly-propylene (PP). The pad and gasket are made of Ethylene Vinyl Acetate (EVA) foam. The closure system is designed, comprising of 4 components: Gasketed lid, Lid gasket pad, Screw-on cap, Cap gasket.
More Information

Not Found

No
The device description and performance studies focus on the physical properties and containment capabilities of a chemotherapy waste container, with no mention of AI or ML technologies.

No
The device is a container for waste, not a device used to treat or diagnose a medical condition.

No.
The device is a container for collecting and containing trace chemotherapy waste, not for diagnosing medical conditions.

No

The device description clearly outlines a physical container made of plastic components (Poly-propylene and Ethylene Vinyl Acetate foam) with a specific size, weight, and closure system. It is a hardware device for collecting and containing waste.

Based on the provided information, the Maxcon Two Gallon Chemotherapy Container (Model, MC1321) is not an IVD (In Vitro Diagnostic) device.

Here's why:

  • Intended Use: The intended use is for the "safe collection and containment of trace chemotherapy waste including needles, syringes, and empty vials." This is a containment and disposal function, not a diagnostic test performed on a sample from the human body.
  • Device Description: The description focuses on the physical characteristics of the container (size, material, closure system) designed for waste containment.
  • Performance Studies: The performance studies are related to the physical integrity and safety of the container for waste disposal (puncture resistance, stability, drop test, etc.), not diagnostic accuracy or performance with biological samples.
  • Lack of IVD Characteristics: There is no mention of analyzing biological samples, detecting substances, or providing diagnostic information about a patient's health condition.

IVD devices are used to examine specimens derived from the human body (like blood, urine, tissue) to provide information for diagnosis, monitoring, or screening. This device's function is purely for the safe handling and disposal of medical waste.

N/A

Intended Use / Indications for Use

Maxcon Two Gallon Chemotherapy Container (Model, MC1321) is intended for safe collection and containment of trace chemotherapy waste including needles, syringes, and empty vials. The container is non-sterile, to be single-used in areas with controlled access, such as nurse's stations, pharmacies and chemo treatment rooms, and the target population is for trained health-care professionals.

Product codes

MMK

Device Description

Maxcon Two Gallon Chemotherapy Container (Model: MC1321) is of 2 gallon capability, weight about 470gram, size of 275.6mm (length) ×181.5mm (width)× 275mm (height), and the maximum allowable gross mass of the container defined by the company is 2 Kg.There is no feature to bend, break, or shear needle (includes blunting and melting of needle)in the containers.

The container is made of base+gasketed cap+screw-on cap. The plastic components are made of injection-moulded of Poly-propylene (PP). The pad and gasket are made of Ethylene Vinyl Acetate (EVA) foam.

The mechanism of temporarily locking and permanently locking includes a special structure embedded in the screw thread. When the cap is screwed to the end, a gap will engage a bulge, with a sound of click, and the cap will not be opened again.

The container base: Size (mm) 275.6x181.5x275mm, Material PP, Weight 375 Gram, Color Translucent yellow.

Wall Thickness of the container (mm): Base thickness 1.6±0.1, Lid thickness 1.6±0.1, Cap thickness 1.6±0.1.

The closure system is designed, comprising of 4 components:
Gasketed lid: Material: P.P, Size: 181.5mmX261.4mm, Weight: 94 grams.
Lid gasket pad: Material: Ethylene Vinyl Acetate (EVA) foam, Size: 175mmX255mm, Weight: 10 grams.
Screw-on cap: Material: P.P, Size: 108mmX17mm, Weight: 22 grams.
Cap gasket: Material: Ethylene Vinyl Acetate (EVA) foam, Size: 103mmX1mm, Weight: 2 grams.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Not Found

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Trained health-care professionals in areas with controlled access, such as nurse's stations, pharmacies and chemo treatment rooms.

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Non-clinical testing successfully passed through tests of:

  • Puncture Resistance (based on ASTM F 2132-01 (2008)) - Passed
  • Container Stability (based on ISO 23907:2012)- Passed
  • Drop/impact Test (based on ISO 23907:2012)-Passed
  • Handle Strength (based on ISO 23907:2012)- Passed
  • Stacking Test (based on 49CFR 178.606)- Passed
  • Vibration Test (based on 49CFR 178.606)-Passed
  • Test to demonstrate MAXCON TWO GALLON CHEMOTHERPAY CONTAINER suitable for chemotherapy drugs-Passed
  • Chemical Resistance test (with H2SO4 and NaOH used to demonstrate its chemical resistance ) -Passed
  • Shelf-life study (including real-time aging and accelerated-time aging to support its shelf life of 3 years)-Passed

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s)

K964858

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 880.5570 Hypodermic single lumen needle.

(a)
Identification. A hypodermic single lumen needle is a device intended to inject fluids into, or withdraw fluids from, parts of the body below the surface of the skin. The device consists of a metal tube that is sharpened at one end and at the other end joined to a female connector (hub) designed to mate with a male connector (nozzle) of a piston syringe or an intravascular administration set.(b)
Classification. Class II (performance standards).

0

Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health and Human Services logo on the left and the FDA logo on the right. The FDA logo features the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue text.

January 3, 2019

Ningbo Maxcon Medical Technology Co., Ltd. Yang Song Sales Manager No.30 Dongbei Road/No.228 Dong Xin Road, Dong Qiao Town Ningbo, 315157 Cn

Re: K180983

Trade/Device Name: Maxcon Two Gallon Chemotherapy Container Regulation Number: 21 CFR 880.5570 Regulation Name: Hypodermic Single Lumen Needle Regulatory Class: Class II Product Code: MMK Dated: November 22, 2018 Received: December 7, 2018

Dear Yang Song:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal

1

statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/CombinationProducts/GuidanceRegulatoryInformation/ucm597488.html; good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm.

For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely.

Elizabeth F. Claverie -S

For Tina Kiang, Ph.D. Acting Director Division of Anesthesiology, General Hospital, Respiratory, Infection Control, and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

2

Indications for Use

510(k) Number (if known) K180983

Device Name

Maxcon Two Gallon Chemotherapy Container (Model, MC1321)

Indications for Use (Describe)

Maxcon Two Gallon Chemotherapy Container (Model, MC1321) is intended for safe collection and containment of trace chemotherapy waste including needles, syringes, and empty vials. The container is non-sterile, to be single-used in areas with controlled access, such as nurse's stations, pharmacies and chemo treatment rooms, and the target population is for trained health-care professionals.

Type of Use (Select one or both, as applicable)

| Prescription Use (Part 21 CFR 801 Subpart D)

|X Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Druq Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

3

Image /page/3/Picture/0 description: The image shows the word "MAXCON" in bold, black letters. The letters are sans-serif and appear to be a custom font. There are three vertical lines to the left of the word. The plus sign is in the middle of the letter "O".

510(k) Summary

The assigned 510(k) number is:K180983

Date Prepared: December 29, 2018 1.

Submitter's Identification: 2.

Ningbo Maxcon Medical Technology Co.,Ltd

Address: No.228,Dongxin Road,Dongqiao Town,Yinzhou.Ningbo,Zhejiang province,China

Contact person: Mr.Song Yang, sales manager of business department

Telephone: (+86)18656003277

E-mail: song.yang@maxcon.net.cn

Zip code: 315157

3. Name of the Device:

Common Name:Sharps Disposal Container

Trade Name:Maxcon Two Gallon Chemotherapy Container (Model: MC1321)

Classification name: Hypodermic single lumen needle

4. Classification Information:

Product Code: MMK

Device Class: II

CFR Reference: 21 CFR880.5570

Classification Panel:General Hospital

ട്. Predicate Device Information:

The Maxcon Two Gallon Chemotherapy Containers (Model: MC1321) are equivalent to Bemis Two Gallon Chemotherapy Containers (K964858) manufactured by Bemis Manufacturing Company, located in 300 Mill Street, Sheboygan Falls, WI 53085, USA, which has the same intended use and is similar in design to the predicate devices.

4

Image /page/4/Picture/0 description: The image shows the word "MAXCON" in a bold, sans-serif font. The letters are black, and there are two diagonal lines to the left of the "M". There is a plus sign inside the letter "O".

Intended use / Indication for Use: 6.

Maxcon Two Gallon Chemotherapy Container (Model, MC1321 ) is intended for safe collection and containment of trace chemotherapy waste including needles, syringes, and empty vials. The container is non-sterile, to be single-used in areas with controlled access, such as nurse's stations, pharmacies and chemo treatment rooms, and the target population is for trained health-care professionals.

7. Device Description:

Maxcon Two Gallon Chemotherapy Container (Model: MC1321) is of 2 gallon capability, weight about 470gram, size of 275.6mm (length) ×181.5mm (width)× 275mm (height), and the maximum allowable gross mass of the container defined by the company is 2 Kg.There is no feature to bend, break, or shear needle (includes blunting and melting of needle)in the containers.

The container is made of base+gasketed cap+screw-on cap. The plastic components are made of injection-moulded of Poly-propylene (PP). The pad and gasket are made of Ethylene Vinyl Acetate (EVA) foam.

The mechanism of temporarily locking and permanently locking

Image /page/4/Figure/8 description: The image shows two diagrams of a product assembly. Each diagram shows a base with a circular indentation, a circular cap, and a ring. The cap is shown with a curved arrow indicating a twisting motion, and the ring is labeled with the number "2" and an arrow pointing towards the base. The base also has the number "1" and an arrow pointing towards the circular indentation.

As Indicated in the above-mentioned pictures, there is a special structure embedded in the screw thread, which can lock the cap firmly and be resistant to manual opening.

    1. A bulge located in the end of screw thread.
    1. A gap located in the beginning of screw thread

5

Image /page/5/Picture/0 description: The image shows the word "MAXCON" in a bold, sans-serif font. The letters are all capitalized and black. To the left of the word are three vertical black lines. The "O" in "MAXCON" has a plus sign inside of it.

When the cap is screwed to the end, the gap will engage the bulge, with a sound of click, and the cap will not be opened again.

Information of the container base

Size (mm)MaterialWeightColor
275.6x181.5x275mmPP375 GramTranslucent yellow

Wall Thickness of the container (mm)

Base thicknessLid thicknessCap thickness
$1.6\pm0.1$$1.6\pm0.1$$1.6\pm0.1$

The closure system is designed, comprising of 4 components:

Gasketed lidLid gasket padScrew-on capCap gasket
Material: P.PMaterial: EthyleneMaterial: P.PMaterial: Ethylene
Size:
181.5mmX261.4mmVinyl Acetate (EVA)
foamSize: 108mmX17mmVinyl Acetate (EVA)
foam
Weight: 94 gramsSize: 175mmX255mmWeight: 22 gramsSize: 103mmX1mm
Weight: 10 gramsWeight: 2 grams

6

Image /page/6/Picture/0 description: The image shows the word "MAXCON" in a bold, sans-serif font. The letters are all capitalized and black. There are two diagonal lines to the left of the word. The letter "O" in "CON" has a plus sign inside of it.

8. Comparing to Predicate Device:

Proposed DevicePredicate Device
CharacteristicMaxcon Two Gallon Chemotherapy
container (K180983) manufactured
by Ningbo Maxcon Medical
Technology Co.,Ltd with address in
No.228,Dongxin Road,Dongqiao
Town, Yinzhou.Ningbo,Zhejiang
province,ChinaBemis Two Gallon Chemotherapy
Container (K964858) manufactured
by Bemis Health Care with address in
300 Mill Street Sheboygan Falls, WI
53085, USAS.E.
on
Product CodeMMKMMKSame
Regulation No.21 CFR 880.557021 CFR 880.5570Same
ClassIIIISame
Indications For UseMaxcon Two Gallon Chemotherapy
Container (Model, MC1321 ) is
intended for safe collection and
containment of trace chemotherapy
waste including needles, syringes, and
empty vials.The container is
non-sterile, to be single-used in areas
with controlled access, such as
nurse's stations, pharmacies and
chemo treatment rooms, and the
target population is for trained
health-care professionals.The Bemis Two Gallon
Chemotherapy Container is a sharps
disposal container.It is intended for
the safe disposal of needles, syringes,
and other chemotherapy waste in
areas with controlled access which
typically include nurse's stations,
oncology, pharmacies, and
chemotherapy treatment rooms.Same
Size2Gallon2GallonSame
Dimensions292mmx193mmx216 mm215.9mmx292.1mmx193mmDifferent
Weight range470 gram1LB 2OZDifferent
Material used of
plastic componentsPoly-propylenePoly-propyleneSame
Material used of Pad
and gasketEthylene Vinyl Acetate (EVA) foamEthylene Vinyl Acetate (EVA) foamSame
Claimed sterilization
cyclesNon-sterileNon-sterileSame
End-color changeNo color changeNo color changeSame
Where it usedcontrolled access, such as nurse'scontrolled access, such as nurse'sSame
Ningbo Maxcon Medical Technology Co., Ltd
stations, pharmacies and chemo
treatment roomsstations, pharmacies and chemo
treatment rooms
Base ColorYellowYellowSame
ClarityTranslucent of the base,allowing
visibility of fill levelTranslucent of the base, allowing
visibility of fill levelSame
Device designBase+Gasketed lid +screw on plastic
capBase+Gasketed lid +screw on plastic
capSame
Single use or notSingle used and disposable onesSingle used and disposable onesSame
Non-clinical testingSuccessfully passed through tests of
puncture resistance, leak resistance,
stability,free standing and impact
resistanceSuccessfully passed through tests of
puncture resistance, leak resistance,
stability, free standing and impact
resistanceSame
Operation wayOne-handed operationOne-handed operationSame
Method of
ManufactureInjection MoldedInjection MoldedSame
Performance,
effectiveness and
safetyThe containers successfully passed
through the tests described in
  1. FDA Recognized Consensus
    Standards, 6-215, ASTM F2132
    -01 Standard Specification for
    Puncture Resistance of Material
    Used in Containers for Discarded
    Medical Needles and Other Sharps
    (Reapproved 2008)e1,
  2. FDA Recognized Consensus
    Standards, 6-293, ISO 23907 First
    edition 2012-09-01Sharps injury
    protection - Requirements and test
    methods - Sharps containers,
  3. Occupational Safety and Health
    Administration - Occupational
    Exposure to Bloodborne
    Pathogens; final rule (29 CFR
    1910.1030; Federal Register 1991
    December 6; 56, No.
    235:64175-82. | The predicated device was
    cleared in 1990s, with its test
    conducted as per:
  4. ASTM proposed standard for
    puncture resistance/ECRI
    Puncture Resistance Criteria
  5. ECRI Health Devices Leak
    Resistance Criteria
  6. OSHA
  7. ECRI free-standing capability
    criteria | Similar |

7

/MAXCGN

宁波迈克斯康医疗科技有限公司 Ningbo Maxcon Medical Technology Co., Ltd

8

Image /page/8/Picture/0 description: The image shows the word "MAXCON" in a bold, sans-serif font. The letters are black, and there are three black lines to the left of the "M". A plus sign is embedded in the letter "O".

Ningbo Maxcon Medical Technology Co., Ltd

9. Performance data

Maxcon Two Gallon Chemotherapy Container has similar indications for use and technological

characteristics as the predicate device (K964858) manufactured by Bemis Health Care, based on the

subject device, Maxcon Two Gallon Chemotherapy container, is found to successfully pass through the

tests as follows:

  • Puncture Resistance (based on ASTM F 2132-01 (2008)) - Passed
  • Container Stability (based on ISO 23907:2012)- Passed
  • Drop/impact Test (based on ISO 23907:2012)-Passed
  • Handle Strength (based on ISO 23907:2012)- Passed
  • Stacking Test (based on 49CFR 178.606)- Passed
  • Vibration Test (based on 49CFR 178.606)-Passed
  • Test to demonstrate MAXCON TWO GALLON CHEMOTHERPAY CONTAINER suitable for chemotherapy drugs-Passed
  • Chemical Resistance test (with H2SO4 and NaOH used to demonstrate its chemical resistance ) -Passed
  • Shelf-life study (including real-time aging and accelerated-time aging to support its shelf life of 3 years)-Passed

Therefore, although the subject device and predicate device differ in container dimensions and the weight, it is believed that the difference in technological characteristics do not impair the subject device from the intended functions of disposal and storage of trace chemotherapy waste including needles, syringes, and empty vials, and did not compromise the SE (Substantially equivalent) to the predicated device.

9

Image /page/9/Picture/0 description: The image shows the word "MAXCON" in a bold, sans-serif font. The letters are black, and the background is white. There are three diagonal lines to the left of the letter "M". A plus sign is located in the center of the letter "O".

Discussion of Clinical Tests Performed: 10.

There was no clinical testing required to support the medical device -

11. Conclusions:

We have demonstrated in this 510(k) submission that based on the nonclinical tests performed the subject device, Maxcon Two Gallon Chemotherapy Container, is as safe, as effective and performs at least as safely and effectively as the legally marketed predicate device, Bemis Two Gallon Chemotherapy Container (K964858)